NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Svf Endurance Cayman Ltd10% Owner2025-10-08466,242$6.05
$2.82MSell
Svf Endurance Cayman Ltd10% Owner2025-10-0772,133$5.60
$404.16kSell
Svf Endurance Cayman Ltd10% Owner2025-10-0673,955$5.69
$420.66kSell
Svf Endurance Cayman Ltd10% Owner2025-10-03450,342$5.56
$2.50MSell
Vicki L. SatoDirector2025-10-0122,000$5.84
$128.39kSell
Vicki L. SatoDirector2025-09-0222,000$4.99
$109.80kSell
Vicki L. SatoDirector2025-08-0122,000$4.99
$109.69kSell
Mark EisnerEVP and Chief Medical Officer2025-07-173,586$5.47
$19.63kSell
Mark EisnerEVP and Chief Medical Officer2025-07-156,796$5.47
$37.16kSell
Vicki L. SatoDirector2025-07-0122,000$5.10
$112.20kSell

1 of 3

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sb Investment Advisers Uk Ltd12.01%16,684,041$96.77MInstitution
Alaska Permanent Fund Corp12.00%16,666,668$96.67MInsider
Blackrock Inc11.63%16,153,190$93.69MInstitution
Svf Endurance Cayman Ltd11.25%15,621,369$90.60MInsider
Vanguard Group Inc9.52%13,227,066$76.72MInstitution
Arch Venture Management LLC9.30%12,916,663$74.92MInstitution
Temasek Holdings Private Ltd3.96%5,499,999$31.90MInsider
State Street Corp3.78%5,254,712$30.48MInstitution
Dhabi Investment Authority Abu2.64%3,666,666$21.27MInsider
Fmr LLC2.56%3,558,655$20.64MInstitution

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR67.46%32.54%Net SellingNet Selling
GERN80.63%1.09%Net BuyingNet Buying
GYRE2.05%97.95%Net Buying
ABUS29.81%70.19%Net Selling
GHRS70.22%0.00%

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 79.79% institutional shareholders, 38.48% Vir Biotechnology insiders, and 0.00% retail investors. Alaska Permanent Fund Corp is the largest individual Vir Biotechnology shareholder, owning 16.67M shares representing 12.00% of the company. Alaska Permanent Fund Corp's Vir Biotechnology shares are currently valued at $97.67M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.